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Emergency Medicine and COVID-19:
now and next year
Theodore A. Christophera, Adrienne N. Christopherb
Abstract

The COVID-19 pandemic is responsible for infecting to date more than 93 million people worldwide and causing more than 2 million
deaths. That the vast majority of deaths have occurred in the United States (U.S.) can be attributed to nonadherence by Americans to
basic public health mitigation strategies that are known to curtail coronavirus spread. Emergency Departments (ED’s) throughout the
U.S. experienced a dramatic decrease in patient visits during the ﬁrst surge of COVID-19, followed by an ED patient visit rebound to
approximately 80% of pre-COVID-19 numbers, which have remained relatively stable through the current second COVID-19 surge.
The pandemic highlighted the signiﬁcant role that hospital ED’s and emergency physicians played in combatting COVID-19 “on the
front lines.” Wearing extensive and escalating personal protective equipment (PPE) layers became the norm in seeing emergency
patients, and many infrastructure and process changes occurred included evaluating and treating patients in outdoor tents,
cohorting conﬁrmed and suspected COVID-19 patients in designated ED and hospital sections, and repeatedly amending COVID-19
evaluation and treatment guidelines as more information became available on a sometimes daily basis. Regarding other clinical
venues in which emergency physicians were working during COVID-19 surges, Observation Unit patient visits decreased, although
patient acuity increased; urgent care (UC) patient visits decreased dramatically, whereas Telehealth (TH) patient visits to our 24/7
available platform, JeffCONNECT, saw a dramatic increase in activity. Remdesivir, Dexamethazone and more recently, the
monoclonal antibody Bamlanivimab, have formed the mainstay of treatment offered to our patients with COVID-19; all these agents
are offered to patients in our ED’s and Observation Unit. The current second COVID-19 surge, with our ED and hospital patient visits
remaining essentially stable, has intensiﬁed the public health crisis as record numbers of U.S. patients continue to acquire COVID-19
and die. With ED patient care processes being optimized to treat the inﬂux of COVID-19 patients, and ED geography being adjusted
within ED’s and expanding maximally to areas outside the ED’s but still within the conﬁnes of hospital walls, emergency physicians
have taken the lead in caring for patients remotely via on demand TH Virtual ED visits. Rather than continuing to request the patients to
come to us, emergency physicians are evolving to assess patients remotely and are embracing health care delivery models that bring
acute unscheduled medical care to patients at home. This will include also prioritizing health wellness, health care disparities, and
health equity, as Emergency Medicine (EM) and emergency physicians begin to collectively address community and patient social
determinants of health, especially in vulnerable populations and communities.
Keywords: Coronavirus, COVID-19, Emergency Medicine

deaths world-wide. In the United States, there will have
been more than 23 million cases, and nearly 390,000
deaths – greater than 3000 deaths per day, or 1 citizen
every 20 seconds. In the state of Pennsylvania, there are
now 750,000 cases and 18,000 deaths, with Philadelphia,
the city where the senior author practices Emergency
Medicine, seeing greater than 100,000 cases and 4000
deaths. Comparatively, in China, a country with almost 5
times the population as the United States, there have been
just a little over 97,000 cases, and only 4700 reported
deaths.[1]

Introduction
At the time of this writing, COVID-19 will be responsible
for more than 93 million cases and more than 2 million
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Coronavirus in the United States
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Why is there so much COVID-19 in the United States (U.
S.) compared to other countries? As an example, one only
needs to look at the COVID-19 surge history, comparing
COVID-19 citizen shut down efforts between the U.S. and
Europe, to garner clues. The identiﬁcation of whereabouts
of individual citizens is easily done by tracking mobility by
phone GPS. Regarding the ﬁrst COVID-19 surge, from
April through June 2020, the U.S. as a country responded
to the ﬁrst COVID-19 surge by returning to a baseline
COVID-19 positivity of 20,000 compared to a return to
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Figure 1. Baseline COVID-19 positivity between the United States and Europe in the ﬁrst and second COVID-19 surges.

COVID-19 baseline positivity of 5000 cases in Europe. In
July, the baselines were 70,000 cases and 10,000 cases for
the U.S. and Europe, respectively; in August, the baseline
return cases were 40,000 vs. 15,000, and in September
equal between the 2 at 35,000 baseline COVID-19 positive
cases. However, during the beginning of the predictable
second COVID-19 surge in the fall, in November and
December, the U.S. was averaging 220,000 cases vs. only
35,000 cases in Europe, Figure 1.[2] Why? There was
simply much less individual citizen adherence to basic
public health measures to “shut down” coronavirus
spread, such as masking and maintenance of social
distancing, in the U.S. compared to Europe. Unfortunately,
this lack of adherence to proven mitigation strategies to
control the spread of COVID-19 was most likely due to
political inﬂuences on citizen accountability for utilizing
mitigation strategies. The result has been the U.S.
population suffering the most deaths of any other country
in the world from what is turning out to be the most deadly
pandemic of this century. This is true despite the
realization that mitigation strategies, while working
successfully to contain the spread of COVID-19, do not
necessarily have to “shut down” a country or its economy.

becoming much more involved in the transitions of care of
those patients discharged patients from emergency departments to their homes or other community settings. It is no
longer the norm that emergency physicians are only
concerned with care of the patients they treat while in their
EDs.
The Thomas Jefferson University Hospital (TJUH) ED,
along with its afﬁliate Methodist Hospital (MH) ED,
provide care to over 120,000 patients a year. The TJUH
Center City (CC) ED serves as the ﬂagship academic
emergency department for the Sidney Kimmel Medical
College and for a 3-year EM residency program which
trains 51 EM residents annually. The 660+ bed TJUH is a
level one intensive trauma center, a certiﬁed stroke center,
a major cardiac care center with 24/7 cardiac catheterization capabilities, and is a major specialty and tertiary
medical and surgical transfer destination for patients in the
Philadelphia region.
Managing the COVID-19 surge in a Philadelphia
emergency department
During the ﬁrst surge of COVID-19 (March through June,
2020), patient visits to the CC and MH ED’s fell
dramatically to less than half their normal volumes. This
trend of a marked decrease in ED patient visits during
the ﬁrst COVID-19 surge was common throughout the
country, not only in academic, but also suburban,
community, and rural hospitals. The ﬁrst COVID-19
surge was fret with grave medical uncertainty and fear of
the coronavirus, affecting not only patients coming in to
hospitals and emergency departments, but also providers,
including physicians, residents, students, nurses, and
ancillary staff taking care of patients. With its alarming
number of sudden and unexpected deaths, COVID-19 was
the new “great medical unknown.” When it became
realized as a true lethal pandemic, COVID-19 led to an
entirely new way for ED providers to see and take care of
their patients. For many, it became “see my eyes only”
patient care, through 3 layers of personal protective
equipment (PPE), including surgical and n95 masks and

The evolution of emergency medicine
In recent years, the specialty of Emergency Medicine (EM)
has undergone profound changes in its scope of practice,
with emergency physicians now ﬁnding themselves
practicing in a variety of clinical settings other than
standard emergency departments (EDs). In many institutions and enterprise health systems, emergency physicians
now are the main providers in 24/7 Telehealth (TH)
centers, hospital observation or clinical decision (observation) units (CDU), and urgent care (UC) centers. In many
hospitals, emergency physicians with specialized critical
care training provide signiﬁcant coverage in both medical
and surgical critical care units. Because EM also focuses on
expediting care of patients, it is becoming increasingly
common in many hospitals for the hospitalist medicine
service to fall under the realm of EM. Finally, EM is now
15
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face shields, and Powered Air-Purifying Respirators
(PAPR’s). Some ED’s were better prepared than others
to protect their patients and providers. Due to superlative
and rigorous disaster and pandemic planning for the past
25 years, building on the knowledge and experience
learned from the Severe Acute Respiratory Syndrome,
Middle East Respiratory Syndrome and Ebola pandemics,
Jefferson’s disaster preparedness leaders made sure all
providers and staff were adequately supplied ample PPE
for the COVID-19 pandemic. As an example, during the
ﬁrst COVID-19 surge, each ED physician working on shift
was provided with their own personal PAPR, to be worn
during all aerosolizing procedures, and otherwise at each
provider’s discretion.
During the second COVID-19 surge (October through
the present time), patient visits have risen to approximately
90% of pre-COVID ﬁrst surge visit levels, but our ED’s,
and ED’s across the country, are seeing a much higher
acuity level of patients, resulting in an increased admission
rate of ED patients into the hospital. At the present time,
there remain record numbers of Americans acquiring
COVID-19 infection, and dying from the disease on a daily
basis. Recent major U.S. Thanksgiving and Christmas
Holidays occurring at the end of 2020 resulted in
congregate gatherings and a return to nonadherence to
COVID-19 mitigation strategies, accounting at least in
part for the current record COVID-19 surge in numbers
and deaths.

positive patients under investigation (PUI) are being
discharged to home based on age risk assessment age
(<55 low; between 55 and 64 moderate; >64 high) and
ability to home monitor with pulse oximetry. ED patients
deemed stable enough for discharge are those being
deemed “low risk,” and able to maintain a pulse oximetry
≥95%, heart rate <100, and respiratory rate <20. Those
deemed unstable for discharge are being admitted to either
the hospital’s short stay CDU, or if sick enough, to either
the hospital’s inpatient service or an ICU. Patients suitable
for the CDU include anyone not receiving Remdesivir who
may have a pulse oximetry reading >95% but with
comorbidities, ambulatory desaturation no lower than
90% to 94%, a 4C Mortality Score  7, and COVID-19
“labs” as follows: D-dimer <1000 ng/mL, CRP <10 mg/L,
Procalcitonin 0.5 ng/mL. All other ED COVID-19
positive or PUI patients, as well as any patient meeting
criteria for Remdesivir and steroid treatment, or requiring
oxygen, are being admitted to the hospital inpatient or ICU
service.
Evidenced-based treatment guidelines
As of this writing, U.S. hospitals by and large continue to
administer Remdesivir and other agents based on federal
Center for Disease Control recommendations. Evidence
supporting Remdesivir administration is based on the ﬁnal
report of the ACTT-1 placebo controlled clinical trial study
which included 1062 hospitalized COVID-19 lung involved
patients from 10 countries, published in October, 2020.[4]
Early on in their illnesses, patients receiving Remdesivir
demonstrated a decreased time to recovery (10 vs. 15 days),
and a trend toward decreased mortality. Evidence supporting dexamethasone treatment is based on results of the
United Kingdom “Recovery” clinical trial published on July
17, 2020. In this study, 6425 hospitalized patients were
randomized to receive 6 mg (oral or IV) of dexamethasone
later in their illness course, or usual treatment course (no
dexamethasone) for up to 10 days.[5] Ventilated patients
treated with dexamethasone reduced their 28 day mortality
rate by 36%, and by 18% in those patients additionally
receiving oxygen. There was no beneﬁt for patients not
receiving respiratory support, or for patients receiving
dexamethasone earlier in the course of their illness. Late
administration efﬁcacy of dexamethasone is attributed to its
more efﬁcacious affect against the patient’s inﬂammatory
response, which is thought to occur later on in the disease
process. In the rare instance when corticosteroids cannot be
used, the tumor necrosis factor antagonist Baricitinib is
recommended only in combination with Remdesivir for
hospitalized, nonintubated COVID-19 patients requiring
oxygen supplementation.
The Lilly monoclonal antibody (MAB) Bamlanivimab
was approved Nov 6, 2020, by the U.S. FDA, followed
shortly after by approval of additional MAB’s (Casirivimab, Imdevimab) for mild to moderate symptomatic
COVID-19 patients at high risk but not sick enough to be
admitted to the hospital. The National Institute of Health
(NIH) panel recommends that all MAB’s should not be
considered the standard of care for COVID-19 treatment
outside of a clinical trial. Out health system has chosen to
mostly use Bamlanivimab in select patients. It has an

Testing and admission procedures
State Health Departments throughout the country have
encouraged EDs to test symptomatic patients and patients
with signiﬁcant COVID-19 exposures to close contacts.
Testing is not recommended for patient convenience,
especially if patients have no symptoms or no exposure
concerns. Due to an overwhelming number of patients
coming in to the EDs for testing on their own, or by referral
from physician ofﬁces, many ED’s, especially those overwhelmed with patients, refer patients out to COVID-19
testing sites. One of our health system testing sites is housed
in a constructed outdoor tent in the driveway of our ED.
Testing guidelines, however, continue to evolve and change
almost on a weekly basis. For example, testing for patients
traveling to see family was in the past strongly discouraged.
However, as of mid-January, all passengers ﬂying in to the
U.S. must have proof of a negative COVID-19 test within 3
days of ﬂying.
Commensurate with COVID-19 surges, Pennsylvania
has seen a signiﬁcant increase in COVID-19 testing
positivity rate (presurge: 5%, surging >15%).[3] The most
common COVID-19 tests used in our facility are the “gold
standard” nucleic acid ampliﬁcation reverse transcriptase
polymerase chain reaction tests, which detect viral RNA
genetic material present at a given point in time in nasal
pharyngeal, nasal, oral-pharyngeal, oral, or saliva specimens. COVID-19 Antigen and antibody tests are still being
developed or ﬁne tuned, with indications for obtaining
them still to determined.
Likewise, COVID-19 ED evaluation and treatment
pathways continue to be created, tweaked, and altered.
Most recently, ED COVID-19 positive or presumptive
16
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infusion time of 60 minutes, which has not deterred some
hospitals and health system administrators to suggest it be
administered in their EDs, despite both ED and hospital
bed capacity issues resulting in excessive boarding of
admitted patients in the ED during the COVID-19
pandemic. The State Department of Health (DOH) has
suggested alternative hospital or outpatient sites such as
infusion centers, closed clinics, or ambulatory care or
surgical centers, to administer any MAB agents requiring
prolonged infusion times. At my institution, we are
considering administering MAB’s in our CDU for speciﬁc
patients, including undomiciled or psychiatric patients. To
date, only 48 patients (25 in ICU’s) have received
monoclonal antibody infusions to date in any of our 14
hospitals within the health system, with less than a handful
of patients treated in any of the health system ED’s. Across
the country, there is wide variation in hospitals treating
COVID-19 patients with MAB’s, with some institutions
prescribing them only in ill patients with hypoxia who are
over the age of 65, and others forgoing any MAB
treatment at all for any COVID-19 or PUI patient.
Because of the pro-thrombotic nature of COVID-19
illnesses, prophylactic dose anticoagulation based on
venous thromboembolism prevention guidelines should
be prescribed for hospitalized COVID-19 patients. As of
mid-January, 2021, other potential COVID-19 treatment
modalities, including additional antivirals, antiparasitic
agents (Ivermectin), blood-derived products such as
convalescent plasma and hyperimmune globulins, and
immunomodulators (besides corticosteroids) such as
cytokine inhibitors and interferon, are considered investigational or as yet unproven therapies and are not currently
recommended for routine COVID-19 treatment. Similarly
adjunct therapies such as Vitamin C, Vitamin D, or zinc
supplements are not currently recommended beyond
dietary allowance. For COVID-19 treatment decisionmaking assistance for outpatients as well as inpatients, the
newest up-to-date therapeutic guidelines can be found at
COVID19treatmentguidelines.nih.gov.[6] It is best to treat
these National Institute of Health Expert Panel Treatment
Guidelines as a “living document,” as changes are often
made based on new research evidence or clinical
experience in treating this novel disease.

existing ED patients to alternative treatment and evaluation sites within the hospital, and cohorting patients in
designated areas of the ED. The highest level of
cooperation and support from hospital administration
at the most senior level is needed for these ED process
changes to happen. This is in addition to customary
measures (ie, surgery schedule soothing, “pulling” and
transporting admitted ED patients rapidly to clean and
ready inpatient beds, admitting and transferring appropriate patients to afﬁliated hospitals with bed capacity,
expediting discharge of inpatients, or transferring them to
a designated discharge lounge, etc.) that need to be taken
to alleviate the ED boarding of admitted patients now
exacerbated by the COVID-19 pandemic. Chaotic ED
environments from the COVID-19 pandemic are now
rampant across the country.
Other adaptive ED process changes have included
expanding ED consultation options. In addition to the
customary in-person, traditional face-to-face ED consultation by our specialist colleagues, optimizing virtual
telemedicine consults via IPADs and Robots, and utilizing
phone and virtual internet technology has given rise to the
electronic medical record remote “interprofessional collaboration” consultation, which is then documented in the
patient’s medical record. The latter 2 new consultation
modalities have allowed consultation by specialists for ED
patients to occur remotely from anywhere.
A sicker ED patient population has coincided with more
less ill, nonurgent patients seeking medical care via TH.
“Virtual ED visits” have increased exponentially during
both COVID-19 surges. EM physicians can now provide
“acute unscheduled care” to these patients 24/7 via a TH
health care delivery platform outside of the ED. After their
virtual ED visits, patients can now be referred to the best
clinical follow up setting – UC, the ED, outpatient
radiology suites for imaging, private physician ofﬁces or
clinics, or these days, the appropriate COVID-19 testing
site. COVID-19 related delayed care for critical time
dependent diagnoses like stroke, myocardial infarction, or
sepsis is now reduced as these patients, who previously
avoided seeking health care, now are being evaluated by
TH, with appropriate patients referred immediately to the
ED to address these time dependent illnesses. In addition to
resulting in better medical care, these TH visits are a
fraction of the cost to patients, who save money not paying
for unnecessary ED visits. As an added beneﬁt, TH patient
care requires adoption of new technical and communication skills for some EM physicians, who now have more
time to interact warmly and empathetically with patients
they see via TH. These physicians realize improved patient
experiences and better work–life balance.
Mirroring the decrease in number of patients going to
ED’s during the ﬁrst COVID-19 pandemic surge because
of fear of contacting COVID-19 was the dramatic decrease
in patients seeking care in UC centers – from 70 to 90
patients per day pre-COVID-19 to currently 10 to 25
patients per day. This has resulted in 2 of our UC centers
closing. Interestingly, like in the ED’s, UC patient volumes
rebounded during the time between the ﬁrst and second
COVID-19 surges, but not to previous pre-COVID-19 UC
patient volumes. However, during the current second
COVID-19 surge, both ED and UC patient volumes have

How COVID-19 affected telemedicine and urgent
care facilities
In response to the COVID-19 pandemic, many EDs have
dramatically changed their operational processes and
geographic landscapes. To minimize exposure to ED staff,
some ED’s have implemented virtual remote teletriage of
presenting patients. Obtaining vital signs at the same time
as teletriage remains a challenge in some clinical ED
settings, as has recognizing and quickly acting upon
critical imaging and other testing results ordered from
teletriage. Effective communication among physicians,
advanced practice practitioners, nurses, and technicians
becomes paramount while working in such challenging
new ED geographies. Identifying both COVID-19 and PUI
ED patients, and deciding where they go, both within and
outside the ED, for additional evaluation and treatment
needs to be carefully planned for. It often involves moving
17
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Table 1

How COVID-19 Affected ED Metrics
ED Metrics
Post-COVID
Personal protective equipment
ED patient volume

Increased
Decreased

ED patient acuity
Number of ED to hospital admissions
Boarding hours (ie, length of ED stay
2 hours after admission)
Telemedicine visits
Urgent care visits
Observation unit patients

Increased
Increased
Increased
Increased
Decreased
Decreased

Details
Gown, gloves, mask, face shield in every patient room
More patients treated virtually from home
Patients less inclined to come to hospital due to the pandemic
Higher acuity patients presenting for medical care
Despite lower volume, admissions numbers rising due to acuity
More ED to hospitals admissions leading to increased ED crowding
Increasing number of virtual visits and triaging
Triaging via telemedicine means less patients in urgent care and observation units

not experienced the dramatic decreases seen in the ﬁrst
COVID-19 surge; rather, patient care volumes at both
these clinical venues have remained steady if only slightly
decreased. This has pleased hospital administrators as all
hospitals in our health system have also been able to
maintain a full elective surgery schedule, avoiding the
extreme negative ﬁnancial impact that occurred from the
ﬁrst COVID-19 surge. Individual DOH are once again
watching hospital bed capacity closely. In Pennsylvania
during this second COVID-19 surge, if hospital staff
shortages begin to affect more than 33% of hospitals,
COVID-19 patient surges are greater than 50% and bed
capacity reaches greater than 90%, the State DOH will
demand hospitals decrease their elective procedures and
surgeries by 50% to accommodate medical needs of
patients in their communities. Table 1 describes the impact
of COVID-19 on various ED metrics.

receive vaccination until late Spring or Summer. Because it
is not known if vaccinated individuals will still be
contagious, or how long immunity will last, it has been
recommended that vaccine recipients maintain mitigation
strategies of mask wearing, social distancing, avoidance of
congregate settings, meeting outdoors rather than indoors
as much as possible, and strict handwashing.
Emergency medicine next year
It may be that Emergency Department providers caring for
patients are going to be wearing masks and adhering to
some degree of social distancing for many years to come.
The COVID-19 pandemic will have lasting effects on
patient and public perceptions about the health risks,
including possible death, from infectious disease and other
possible health pandemics. It may be quite some time
before ED’s begin allowing multiple visitors to accompany
and stay with ED patients during their evaluations. Within
the house of medicine, EM will lead the way to work more
closely and intimately with the public health sector to
prepare not only health care providers, but also citizens
adequately for the inevitable next pandemic. Stockpiles of
PPE, including masks, face shields, PAPR’s, gowns, and
gloves will be plentiful, as will supplies of medications and
medical equipment such as respirators.
“Emergency Medicine” is now morphing into a
discipline being labeled as “Acute Unscheduled Care,”
deﬁned by an ever-expanding scope of practice for
emergency physicians to include working in hospital
observation medicine, UC, EMS-based mobile home care,
and telemedicine. Speciﬁcally, Emergency Medicine Virtual Care seems here to stay. Rather than requiring patients
to come to the hospital or doctor’s ofﬁce, bringing health
care to the patient’s home will become the most logical,
cost-effective, and patient centered health care delivery
modality. Emergency physicians no doubt are at the
forefront of this sweeping change in U.S. health care.
Patients are now seeking out emergency physicians for
their on demand health care by accessing telemedicine
platforms, where they are being directed to the most
appropriate venue and location to address their acute
unscheduled medical care needs.
When patients do arrive to an ED, it may well be a standalone facility with its own laboratory, CT and MRI scans,
and staff separate and far from the hospital. Patient care
from emergency physicians will not end upon their

The pandemic’s impact on healthcare workers
In any pandemic, the degree of psychological impact
always greatly exceeds the degree of medical impact. This
has been especially true with health care workers (HCW’s)
in ED’s across the country. Nearly 300,000 physicians,
nurses, EMS providers, and hospital staff have tested
COVID-19 positive, with greater than 1000 deaths
occurring. Physician burnout, depression, substance use
disorder, and suicide are at all-time highs. For many
HCW’s, re-integration into their lives postpandemic are
more stressful than actually working through the
pandemic.
Fortunately, all HCW’s, including all staff that interfaces
with ED’s, have been deemed priority 1 status to receive
the COVID-19 vaccine. To date, in the U.S. only 2 vaccines
have received FDA emergency use authorization (EUA)
approval for administration. The BioNTech-Pﬁzer vaccine
was approved on December 10, 2020 with the ﬁrst dose
administered the following week. The Moderna vaccine
was approved on December 17, 2020. Second doses for
both vaccines began to be administered early in January,
2021, with 95% efﬁcacy expected for both. Unfortunately,
the process of vaccinating mass numbers of people has
been woefully slow with far less vaccinated by the end of
December (4–5 million) than expected (35–40 million). At
this time, many distribution sites are still in the process of
vaccinating Group priority 1 individuals, with the low-risk
general public, assigned Group 3 priority, expected not to
18

Christopher and Christopher  Emerg Crit Care Med (2021) Vol. 1 No. 1

www.eccmjournal.org

discharge from the ED. Rather, tele-navigators stationed in
ED’s will help patients schedule referral care or follow up
visits, and will assist them in connecting to resources and
other support systems in their communities. Emergency
physician based TH “House calls” will help extend
emergency care beyond hospital walls to patient’s homes.
This will be especially important for patients who do not
have a primary care physician. “Virtual Callback” follow
up visits by the emergency physician who took care of an
ED patient yesterday will be a huge patient satisﬁer.
“Never Discharge!” will become the new slogan and
culture of emergency physicians practicing in ED’s.
Rather, care continuity way beyond the ED visit will be
the new norm, provided by the emergency physician,
resulting in better long-term outcomes for all ED patients.
Finally, COVID-19 has highlighted the racial and ethnic
health care disparities within the U.S. health care system as
we know it. African Americans, Hispanic/Latinos, Native
American Indians, Alaska Natives, and Asian/Paciﬁc
Islanders have been the victims of profound COVID-19
infectivity, transmission, serious illness, and mortality.[7]
With our health care infrastructure stressed to the
maximum, ED’s have become the medical home to
increasing numbers of mental health, substance use
disorder, homeless, and poor patients. Providing compassionate care to ED patients has like never before, become
priority in health care, and this has required the
acknowledgement and recognition of provider and staff
conscious and unconscious biases, not only toward patient
gender and race, but also toward patients identifying as
obese, refugee, LGBTQ, and being victims of sex and labor
trafﬁcking and PTSD. Emergency physicians have now
become major health care stakeholders and providers
addressing the social determinants of health of patients.
Only 20% of a patient’s health is determined by traditional
medical care provided at a hospital or physician ofﬁce,
while 80% is determined by that patient’s surrounding
social structure at home or in the community. Remarkably,
the U.S. is ﬁrst in health care costs/patient capita, but dead
last in spending on social services to assist patients in
addressing their social determinants of health – food,
housing, education, income, poverty, transportation, and
neighborhoods. It is long overdue for EM and emergency
physicians to get on board with extending their patient
care skills outside the walls of the ED, and become
involved in these real determinants of patient health. It is
time for EM physicians to work not only in the acute
unscheduled care business, but also in the patient wellness,
prevention, and health care equity business. Securing the
health and welfare of our patients and communities, in
fact, needs to become a shared responsibility that we, as
emergency physicians, have with other sectors of our
society. As Health Care giant Don Berwick, M.D. suggests,
is it not our societal and medical obligation to address
these “moral” determinants of health?[8] As more and
more emergency physicians rise to the occasion to fulﬁll

this obligation, so will our EM culture be redeﬁned as we
embrace not only acute unscheduled health care delivery
beyond the walls of the traditional ED, but also this new
frontier of health care prevention, wellness, and health
equity.
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